Practice · Cardiac Sciences

Fill your cardiac OTs and cath labs — one procedure line at a time.

We build procedure-specific demand for CABG, TAVR/TAVI, angioplasty, electrophysiology and structural heart programs — measured in scheduled surgeries, not enquiry volume.

Built for Chiefs of Cardiac Sciences, Cardiac Program Directors and Managing Directors of 150+ bed cardiac super-specialty units.

Request a Cardiac Pipeline Blueprint →Review case evidence

OT Utilization

87%

From 27% baseline (9-mo avg.)

IP Admissions

412

vs. 128 baseline (+222%)

ROAS (IP revenue)

11.7×

HIS-verified attribution

CAC / Admission

₹18,420

Down from ₹64,800

Procedure-level demand engineering

We target the procedures that move your P&L, not the ones that fill the OPD queue.

CATCHMENT TIER · PRICE RESTATEMENT

ARPU differs materially between Metro, Tier-2 and Tier-3 catchments. Switch tier to restate every procedure band against the payer mix and package ceilings we observe in that market — not a single all-India number.

Viewing Metro / Tier-1 · Representative catchments: Delhi NCR, Mumbai, Bengaluru, Chennai, Hyderabad, Kolkata, Pune.

CABG (on & off-pump)

₹3.2 L–4.5 L

Second-opinion & PCI-to-surgery conversion

TAVR / TAVI

₹18 L–24 L

High-intent structural heart referrals

Primary & Complex PCI

₹1.8 L–3.2 L

Chest-pain & post-angiogram funnels

Electrophysiology & Ablation

₹2.4 L–6.0 L

AF, VT and device implant intake

Paediatric & Structural Heart

₹4.0 L–14 L

Congenital / valvular referral pathway

Advanced Heart Failure & LVAD

₹22 L–60 L

Transplant-track qualification funnel

Methodology. Base bands reflect RDV's engagement dataset across 47 super-specialty hospitals, reconciled against CGHS/ECHS package rates, state-scheme ceilings (Ayushman Bharat PM-JAY, CMCHIS, YSR Aarogyasri) and empanelled TPA grids. Tier multipliers applied: Metro 1.00× · Tier-2 0.72× · Tier-3 0.55×. Actuals swing with payer mix, consultant-fee split and implant/consumable choice — the written Blueprint restates every band against your own HIS billing history before any spend is committed.

Clinical referral pathway

Intent → triage → consult → admission. Instrumented at every gate.

01 · Intent capture
Symptom-led search + district cardiologist directory targeting.
02 · Medical triage
Trained cardiac nurse triage; ECG/echo report upload before consult.
03 · Consultant handoff
Direct calendar sync to interventional cardiologist / CTVS.
04 · Admission & OT slotting
CRM ↔ HIS tag: admission source, procedure code, OT date.

Case snapshot

3.2× OT utilization, 91% cardiac ward occupancy.

A representative RDV engagement in the Cardiac Sciences practice line. Individual results vary by catchment, clinical capacity and payer mix.

Setting: 342-bed cardiac super-specialty, Tier-1 metro
Duration: 9 months (Q2 – Q4 FY24)
Cohort: n = 1,284 qualified cardiac enquiries
Outcome: 3.2× OT utilization, 91% cardiac ward occupancy

Figures engagement-verified against hospital HIS. No outcome guarantees implied; per NMC advertising guidelines.

Why Chiefs of Cardiac choose RDV

Trust is earned in the operating logic, not the pitch deck.

Cardiologist-led editorial

Every asset co-authored with your interventional cardiologist or CTVS — no ghost-written 'medical' content.

Cath-lab & OT calendar integration

Intake routed against real HIS slot availability, not an isolated marketing CRM.

PCI-vs-surgery clinical logic

SYNTAX-informed triage baked into the intake script — CTVS grows without cannibalising PCI.

Zero device advertising

TAVR, LVAD and ICD demand built through disease education, not brand promotion. DCGI-safe by design.

From an engagement

"For the first time our TAVR pipeline felt engineered, not accidental. The intake logic respected our structural-heart review — that was the unlock."

— Chief of Cardiac Sciences · 342-bed metro cardiac unit (engagement RDV-0417)

Attribution anonymised per client confidentiality; engagement code verifiable in the founder-led review.

Talk directly to the founding partner who ran this engagement.

Request a Cardiac Blueprint →

48-hour founder-led review. Fixed-scope. No lock-in.

Clinical authority

Content your clinicians will co-sign.

Interventional cardiologist-led case narratives (video + text)
CTVS surgical volume disclosure page (per NABH clinical claims norms)
Structural heart tumor-board equivalent for TAVR case review

Compliance posture

Every asset, every claim, medically reviewed.

NMC advertising norms — no outcome guarantees
DCGI compliance for device-related messaging (TAVR, LVAD, ICD)
NABH-sensitive claims review by empanelled cardiologist

Catchment note: Catchment engineering across metros (Chennai, Bengaluru, Hyderabad, Mumbai, Delhi-NCR) and export-patient corridors (Dubai, Muscat, Dhaka, Colombo).

The 21-day diagnostic

What the fixed-scope engagement actually contains — for Cardiac.

No mystery, no scope creep. Each week is instrumented and delivered against a checklist your MD and Chief signs.

Week 1
Cath-lab & CTVS OT-utilisation audit; historical intake teardown.
Week 2
Referring-cardiologist mapping across catchment + export corridors.
Week 3
Procedure-line unit economics; CAC-to-ARPU ceiling per procedure.
Week 4
Founder-led blueprint review with your MD and Chief of Cardiac Sciences.

Where we compound

The unfair edge — for Cardiac specifically.

Only consultancy that binds paid intake to CTVS OT-slot availability in real time
Structural-heart review protocol built into every TAVR enquiry
Export-patient corridors already live in Dubai, Muscat, Dhaka and Colombo

Practice guarantees

What we commit to in writing.

Fixed-scope diagnostic — no retainer, no annual lock-in
HIS-verified attribution — every claimed admission traceable to source
No media markup — you see raw platform invoices at cost
Founder-led — the partner who scopes the engagement does the work

Objections we hear

The three questions MDs ask before signing.

We keep our answers on the record. If yours isn't here, ask it in the qualification form — the founding partner replies personally within 48 hours.

We already run a performance marketing agency.

Most agencies optimise cost-per-lead. We optimise cost-per-admission tied to your HIS — a different measurement stack. Run us alongside your agency for one quarter and let attribution decide.

Our CTVS surgeons won't want to be 'marketed'.

Correct — and neither will we. Content is co-authored, medically reviewed and framed as clinical education. Your surgeons approve every asset before publication and typically become the strongest advocates once they see the referring-cardiologist inbound it generates.

How is this different from a hospital marketing head?

A marketing head owns brand and OPD footfall. We own IP admissions by procedure line with unit-economics accountability. In practice, we make internal marketing teams more effective — never redundant.

FAQ

The questions Chiefs of Cardiac ask us first.

If yours isn't here, put it in the qualification form — our founding partner will answer it in the 48-hour review.

How do you grow CABG volume without cannibalising PCI?+

We segment intent by lesion complexity and referral origin. PCI-appropriate leads are routed to the cath lab; SYNTAX-high or diabetic multi-vessel leads are triaged to CTVS. Both lines grow in parallel because we're targeting distinct patient cohorts, not the same enquiry twice.

Do you work with cardiac programs under 100 beds?+

Yes, if a dedicated cath lab and CTVS OT exist. Sub-scale programs benefit most from procedure-specific demand engineering because a single TAVR or LVAD case materially shifts P&L.

How is TAVR demand generated compliantly?+

Through educational content on severe aortic stenosis in the elderly, cardiologist-referral pathways and structured second-opinion funnels — never through direct device advertising, which contravenes DCGI norms.

What is the ramp time to full OT utilization?+

8–14 weeks to steady state depending on call-center posture and existing referral network. Our RDV-0417 cardiac engagement reached 87% OT utilization in month 7 from a 27% baseline.

Next step